Year: 2003
Type: article
Abstract: The modern view of probiotic therapy derives from the concept of a well functioning gut barrier and a normal balanced microbiota. The scientific conception of these host defences has changed; the gut barrier was seen primarily as a physical blockade to foreign antigen entry until its active role in shaping the immune response to luminal antigens was deciphered. Concomitantly, recent experimental and clinical studies demonstrate a dependency on healthy host-microbe interaction to cope with antigen challenges, and consequently attribute the gut microbiota an active role in barrier function.1–3
The most fully documented probiotic intervention is the treatment of acute infectious diarrhoea. Well controlled clinical studies have shown that probiotics such as Lactobacillus rhamnosus GG, L reuteri , L casei Shirota, and Bifidobacterium lactis Bb12 can shorten the duration of acute rotavirus diarrhoea.4,5 Numerous publications on different populations have since substantiated the success of specific probiotic strains in the adjunct management of viral …
Source: Gut
DOI: 10.1136/gut.52.3.436
Author: E Isolauri
Institution: University of Turku
Language: English
Subfield: Food Science
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W2015963540
